RDW / MCV ratio

The RDW/MCV ratio improves differentiation between various types of anemia and blood disorders. A high ratio often indicates iron deficiency anemia or thalassemia trait, where cells vary greatly in size despite being small overall. A low ratio suggests macrocytic anemias (B12/folate deficiency) where cells are uniformly large. The ratio is particularly valuable for early iron deficiency detection before anemia develops, distinguishing iron deficiency from thalassemia, and monitoring treatment response.

It also helps identify mixed deficiencies (concurrent iron and B12 deficiency) that individual parameters might miss, guiding more targeted supplementation and treatment decisions.

The RDW/MCV ratio is reassessed yearly as part of a complete blood count. After starting iron, B12, or folate supplementation, retest at 3 months.

At baseline / for screening: Once every 12 months from age 30 as part of a comprehensive panel.

When monitoring an intervention or change: Retest 4 to 8 weeks after starting iron, B12, or folate supplementation for anemia, or after blood loss recovery. Red blood cells take about 120 days to fully turn over, so meaningful changes in cell size and content (MCV, MCH) take 3 to 4 months. Hydration on the morning of the draw shifts concentration-based measures, so reproduce conditions for reliable trends.